Biomedical subjects

Oscar D Almeida

Publications and source records attributed to Oscar D Almeida.

4 recordsLinked to original sources

PubMedDate not supplied

Microlaparoscopic conscious pain mapping in the evaluation of chronic pelvic pain: a case report.

Chronic pelvic pain is a debilitating, life-altering syndrome that negatively affects a woman's quality of life and personal relationships. Many women continue to suffer with pelvic pain despite having undergone multiple medical and surgical treatments. Unfortunately, some women are incorrectly labeled as having psychological illness when organic disease may be present. I report a case of a woman who underwent multiple pelvic and abdominal surgeries before the cause of her pain was identified through microlaparoscopic conscious pain mapping.

Adult↗

PubMedDate not supplied

Awake microlaparoscopy with the Insuflow device.

BACKGROUND AND OBJECTIVES: Patients undergoing laparoscopy often complain of shoulder pain, shivering, or both following laparoscopy. An increase in awake microlaparoscopic procedures has been reported. The objective of this study was to investigate the usefulness of heating and humidifying the carbon dioxide gas for the pneumoperitoneum with the Insuflow device (Lexion Medical, St. Paul, Minnesota) during awake microlaparoscopic procedures. METHODS: Awake microlaparoscopy was performed with the Insuflow device for heating and humidifying the carbon dioxide for the pneumoperitoneum. RESULTS: The incidence of transient shoulder pain in the Insuflow group was 5% compared with 40% in the dry carbon dioxide group. No patient in the Insuflow group complained of shivering, whereas 55% in the control group had shivering. Fogging of the microlaparoscope lens was decreased in the Insuflow group. CONCLUSIONS: Heating and humidifying the carbon dioxide gas produced fewer patient complaints of shoulder pain and shivering and decreased fogging of the microlaparoscope lens compared with procedures done with dry carbon dioxide during awake microlaparoscopic procedures.

Female↗

PubMedDate not supplied

Microlaparoscopic-assisted vaginal hysterectomy in the morbidly obese patient.

OBJECTIVE: The purpose of this study was to demonstrate a minimally invasive, novel variation, microlaparoscopic-assisted vaginal hysterectomy (MAVH) of a previously established technique, laparoscopic-assisted vaginal hysterectomy (LAVH), in the morbidly obese patient. METHODS: This was a prospective, descriptive feasibility study (Canadian Task Force classification 11-2) conducted at a university-affiliated hospital and private community hospital. Seven morbidly obese women with an average body mass index of 45.8 kg/m2 (range, 40.6 to 51.5) underwent microlaparoscopic-assisted vaginal hysterectomy (MAVH). Microlaparoscopic-assisted vaginal hysterectomy (MAVH), classified as Type 1B, including unilateral or bilateral occlusion and division of the ovarian artery(ies), either medial or lateral to the ovary(ies), with or without dissection of the adjacent broad ligament under microlaparoscopic guidance, in addition to incision of the vesicouterine peritoneum. RESULTS: The median duration of surgery was 109.1 minutes (range, 86 to 134), median blood loss was 207 mL (range, 100 to 350), and average length of stay in the hospital was 33.7 hours (range, 23 to 48). The complication rate was 0%. CONCLUSION: Microlaparoscopic-assisted vaginal hysterectomy (MAVH) is a safe and effective, more minimally invasive method of performing laparoscopic hysterectomies in select morbidly obese patients.

Adult↗

PubMedDate not supplied

Microlaparoscopy and a GnRH agonist: a combined minimally invasive approach for the diagnosis and treatment of occlusive salpingitis isthmica nodosa associated with endometriosis.

OBJECTIVE: To evaluate whether occlusive salpingitis isthmica nodosa associated with endometriosis can be diagnosed by microlaparoscopy and managed with medical therapy using leuprolide acetate. METHODS: This was a prospective, nonrandomized study conducted at a university hospital and a private community hospital. It included women with occlusive salpingitis isthmica nodosa associated with endometriosis. Diagnosis of salpingitis isthmica nodosa was made via microlaparoscopy with chromotubation. Patients with occlusive salpingitis isthmica nodosa were treated with leuprolide acetate 3.75 mg administered monthly for 6 months. RESULTS: Tubal patency in occlusive salpingitis isthmica nodosa following medical therapy with leuprolide acetate was evaluated. Thirteen of 16 (81.3%) women with bilateral salpingitis isthmica nodosa achieved patency of both fallopian tubes following treatment with leuprolide acetate; 3 of 16 (18.8%) developed patency in one of the fallopian tubes. All 5 women with unilateral SIN demonstrated bilateral patency following medical therapy. CONCLUSION: Diagnosis of occlusive salpingitis isthmica nodosa can be made by microlaparoscopy. These preliminary results suggest that medical therapy with leuprolide acetate may be the first-line treatment modality for women with occlusive salpingitis isthmica nodosa associated with endometriosis, possibly avoiding a more invasive surgical procedure.

Adult↗